Driving digital therapeutics and innovative care delivery models

Chris Wasden is no stranger to digital health. As chief strategy officer at Twill (previously Happify) Chris is leading the effort to bring Twill’s platform to the pharmaceutical and healthcare industries. Prior to Twill, Chris was a professor at the University of Utah and executive director of the Sorenson Center for Discovery and Innovation, a digital health game incubator. He is the named inventor of 12 issued patents, has been the founding leader in 10 startups and has held leadership positions at JP Morgan and PwC. ZS sat down with Chris to talk about the challenges of scaling digital therapeutics (DTx), innovative delivery models and the future market landscape.

Driving digital therapeutics & innovative care delivery models | ZS